Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Warren

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Breast Cancer Research : BCR|October 9, 2014
Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study IJane Warwick, Hanna Birke, Jennifer Stone, et al.
Radiology|August 26, 2009
Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic featuresFiona J Gilbert, Ruth M L Warren, Gek Kwan-Lim, et al.
Radiology|August 25, 2005
Reading protocol for dynamic contrast-enhanced MR images of the breast: sensitivity and specificity analysisRuth M L Warren, Linda Pointon, Deborah Thompson, et al.
Clinical Radiology|March 8, 2003
Radiology review of the UKCCCR Breast Screening Frequency Trial: potential improvements in sensitivity and lead time of radiological signsR M L Warren, J R Young, L McLean, et al.
Breast Cancer Research : BCR|April 16, 2004
Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]Charlotte Atkinson, Ruth M L Warren, Evis Sala, et al.
Radiology|May 23, 2006
Evaluation of a prospective scoring system designed for a multicenter breast MR imaging screening studyRuth M L Warren, Deborah Thompson, Linda J Pointon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 18, 2012
The heritability of mammographic breast density and circulating sex-hormone levels: two independent breast cancer risk factorsJajini S Varghese, Paula L Smith, Elizabeth Folkerd, et al.
British Journal of Cancer|April 1, 2004
Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?R M L Warren, L G Bobrow, H M Earl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2007
Postmenopausal hormone therapy and changes in mammographic densityFränzel J B van Duijnhoven, Petra H M Peeters, Ruth M L Warren, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2006
Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic densityFränzel J B van Duijnhoven, Petra H M Peeters, Ruth M L Warren, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Breast Cancer Research : BCR|October 9, 2014
Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study IJane Warwick, Hanna Birke, Jennifer Stone, et al.
Radiology|August 26, 2009
Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic featuresFiona J Gilbert, Ruth M L Warren, Gek Kwan-Lim, et al.
Radiology|August 25, 2005
Reading protocol for dynamic contrast-enhanced MR images of the breast: sensitivity and specificity analysisRuth M L Warren, Linda Pointon, Deborah Thompson, et al.
Clinical Radiology|March 8, 2003
Radiology review of the UKCCCR Breast Screening Frequency Trial: potential improvements in sensitivity and lead time of radiological signsR M L Warren, J R Young, L McLean, et al.
Breast Cancer Research : BCR|April 16, 2004
Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]Charlotte Atkinson, Ruth M L Warren, Evis Sala, et al.
Radiology|May 23, 2006
Evaluation of a prospective scoring system designed for a multicenter breast MR imaging screening studyRuth M L Warren, Deborah Thompson, Linda J Pointon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 18, 2012
The heritability of mammographic breast density and circulating sex-hormone levels: two independent breast cancer risk factorsJajini S Varghese, Paula L Smith, Elizabeth Folkerd, et al.
British Journal of Cancer|April 1, 2004
Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?R M L Warren, L G Bobrow, H M Earl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2007
Postmenopausal hormone therapy and changes in mammographic densityFränzel J B van Duijnhoven, Petra H M Peeters, Ruth M L Warren, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2006
Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic densityFränzel J B van Duijnhoven, Petra H M Peeters, Ruth M L Warren, et al.
Pageof 5